Feverfew migraine & headache, health benefits
has been used for centuries for fevers, headaches, stomach aches, toothaches,
insect bites, infertility, and problems with menstruation and labour during
childbirth. More recently, the health benefits of feverfew for migraine
headaches and rheumatoid arthritis have been discovered.
A number of research studies such as
Murphy et al (1988) and Johnson et al (1985) have demonstrated that feverfew can help reduce the frequency and
severity of migraine attacks, if taken regularly over a period of months. Further
reviews such as Ernst & Pittler (2000) which investigated six randomised double blind trials supported the use of feverfew
for the prevention and treatment of migraine, tension headache and associated
are pregnant should not use feverfew because it may cause the uterus to
contract, increasing the risk of miscarriage or premature delivery. People can
have allergic reactions to feverfew. Those who are allergic to other members of
the daisy family (which includes ragweed and chrysanthemums) are more likely to
be allergic to feverfew
Research on Feverfew health benefits:
Institute of Health
Feverfew (Tanacetum parthenium L. Schultz-Bip.). 2006).
monographs, second edition, 2003, page 492-8, Tanaceti Parthenii Herba, Feverfew.
Monographs on selected medicinal plants, vol. 2, 2002, page 317-28, Herba Tanaceti
Pharmacopoeia 5.0, vol. 2, 2005, monograph Feverfew (01/2005:1516).
S, Bone K. The essential guide to herbal safety. 2005, Elsevier-Churchill-Livingstone,
St Louis MI, pages
Master file Herba Tanaceti Parthenii, February 2007.
E, Pittler MH. The efficacy and safety of feverfew (Tanacetum parthenium L.):
an update of a systematic review. Public Health Nutrition. 2000;3(4A):509-14.
MH, Ernst E. The Cochrane Database of Systematic Reviews 2004 Issue 1 (CD002286).
The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. Feverfew for
BK, Pittler MH, Ernst E. Feverfew as a preventative treatment for migraine: a
review. Cephalagia. 1998;18:704–8.
HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and
safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention -
a randomized, double blind, multicentre placebo-controlled study. Cephalalgia.2005;25:1031-41.
BM. Sesquiterpene lactones - Tanacetum parthenium. In: Adverse effects of herbal
drugs, vol. 1. De Smet PAGM, Keller K, Hansel R, Chandler RF (eds). 1992,
Springer Verlag, Berlin
- Johnson, E.S., Kadam, N.P.,
Hylands, D.M. and Hylands, P.J., Efficacy of feverfew as prophylactic
treatment of migraine. Br Med J (Clin Res Ed). 1985 Aug 31; 291(6495):569-73
- Murphy, J.J., Heptinstall, S. and
Mitchell, J.R., Randomised
double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet. 1988 Jul 23; 2(8604):189-92
SD. Preventive treatment of headaches. Curr Opinion Neurol. 2005;18:289-92.
M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts
on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass
spectrometry and automated online extra